Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.9298 | 65 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.8121 | 64 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.81634 | 64 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.64514 | 62 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.79844 | 64 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.00716 | 66 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.03072 | 66 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.78324 | 63 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.77031 | 63 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.74582 | 63 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.80117 | 64 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.7546 | 63 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.86331 | 64 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.8064 | 64 |